Discovery, developed by RetinAI/Ikerian AG, is an AI‑driven data management and analytics platform designed for ophthalmology and broader healthcare. It centralizes multimodal data—such as OCT and fundus images, EHR records, demographics, genetics, and other omics—into a vendor‑neutral, cloud‑based environment. Certified AI modules automatically extract biomarkers, quantify disease progression, and generate real‑world evidence to support clinical decisions, research, and clinical trials. Discovery offers specialized products for clinics, hospitals, and research centers, as well as for pharma and life sciences, enabling secure collaboration, natural‑language cohort search, tele‑ophthalmology workflows, and the development of custom AI models, all while complying with healthcare privacy regulations like GDPR, HIPAA, and PIPEDA.